Erectile Dysfunction (ED)
If you have trouble achieving or maintaining an erection, you may be eligible to participate in this study, which will evaluate the effectiveness of Alfuzosin in treating men with erectile dysfunction (ED) and mild lower urinary tract symptoms (LUTS). Healthy men with erectile dysfunction, 30 to 69 years of age, are eligible.
#1. A double-blind, placebo-controlled, crossover study to evaluate the efficacy of Alfuzosin in treating men with erectile dysfunction (ED) and mild lower urinary tract symptoms (LUTS).
Research locations:
Towson, MD
Physicians Pavilion North
6535 North Charles St., Suite 625
Baltimore, MD 21204
Contact Heather Thomas, hthomas@cua.md or 410-825-5454
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
Contact Debi Robertson, drobertson@cua.md or 410-825-6310 x163
Glen Burnie, MD
806 Landmark Dr., Suite118
Glen Burnie, MD 21061
Contact Virginia Michaels, vmichaels@cua.md or 410-760-9400
Franklin Square
6830 Hospital Drive, Suite 204
Baltimore, MD 21237
Contact Angela Somers, asomers@cua.md or 410-391-6131 x1212
#2. A randomized, double-blind, placebo-controlled, parallel group, multicenter study of the safety and effectiveness of Avanafil in the treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
For additional information go to: www.pfizer.com
Research location:
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
Contact Debi Robertson, drobertson@cua.md or 410-825-6310 x163
|
 |
|
« Current Clinical Trials
|
|
|
|
Erectile Dysfunction (ED)
|
|
|
|
Enlarged Prostate: (Benign Prostatic Hyperplasia/BPH)
|
|
|
|
Bladder Cancer
|
|
|
|
Prostate Cancer
|
|
|
|
Overactive Bladder
|
|